Results 281 to 290 of about 15,400,316 (399)

Clinical relevance of perioperative changes in circulating tumor cells in resectable colorectal cancer. [PDF]

BMC Cancer
Feng Q, Ni C, Zhou F, Zhu J, Sun X, Qin Y, Xiang N, Wu D.   +7 more
europepmc   +1 more source

A very rare case of adult-type granulosa cell tumor

, 2015
R. Giulianelli, Gabriella Mirabile, G. Vincenti, Francesco Pellegrino, G. Soda   +4 more
openalex   +2 more sources

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

Molecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello, Alberto Bardelli   +3 more
wiley   +1 more source

Editorial: Predictive and prognostic value of liquid biopsy biomarkers in metastatic cancers: from basic science, across high throughput profiling up to clinical practice

Frontiers in Oncology
Dorota Kwapisz, Patrycja Pawlikowska, Areti Strati   +2 more
doaj   +1 more source

Detection of circulating tumor cells and microemboli in the blood of lung adenocarcinoma in situ patients case reports. [PDF]

Discov Oncol
Huang Y, Zhang H, Fan D, Wang Z, Qin X, Sun X, Zhu L.   +6 more
europepmc   +1 more source

Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies.

, 2013
Mohammed Talha Shekhani, Ashika-Sita Jayanthy, Nityanand Maddodi, Vijayasaradhi Setaluri   +3 more
openalex   +1 more source

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.

Trends in immunology, 2016
Vinit Kumar, Sima Patel, E. Tcyganov, D. Gabrilovich   +3 more
semanticscholar   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Synthetic lethality by PARP inhibitors: new mechanism uncovered based on unresolved transcription-replication conflicts

Signal Transduction and Targeted Therapy
Marina Kolesnichenko, Claus Scheidereit
doaj   +1 more source

Circulating tumor cells: mechanisms and clinical significance in colorectal cancer metastasis. [PDF]

Mol Cancer
Ren X, Song M, Liu X, He W.
europepmc   +1 more source